Home Font Size: 1 2 3 Send to a Friend
Exton, Pa., November 7, 2006 - Morphotek® Inc., a privately held biopharmaceutical company focused on the discovery and development of...
+ Read the Article
Exton-based Biopharmaceutical Company Recognized for Innovative Product Pipeline Exton, PA, November 1, 2006 - Morphotek®...
Exton, PA, October 12, 2006 -- Morphotek® Inc., a privately held biopharmaceutical company focused on the discovery and development of...
Exton , PA , August 30, 2006 -- Morphotek ® announced today that the European Patent Office has given...
Exton, PA, June 21, 2006- Morphotek, Inc. announced today that the United States Food and Drug Administration has granted Orphan Drug Status to...
Exton, PA - June 8, 2006- Morphotek, Inc. today announced initiation of Phase II efficacy studies in major cancer centers worldwide for its...
Exton, PA - May 17, 2006 - Morphotek, Inc., a biopharmaceutical company, today announced that it has two presentations on its lead monoclonal...
Exton-PA-April 3, 2006 - Morphotek Inc. today announced scientific publications in the February 28th and March 7th issues of the journal The...
Exton, PA, March 13, 2006 -- Morphotek®, Inc. announced today the appointment of Robert Radie as Chief Business Officer and the...
Exton, PA., February 13, 2006 - Morphotek, Inc. today announced that the United States Food and Drug Administration (FDA) cleared its...
Results per page 10 25 50